Coleman Mark's Form 4 filing
Axsome Therapeutics, Inc.AXSM · filed May 29, 2024
- Accession no.
- 0000950170-24-066175
- Filed
- May 29, 2024
- Trade date
- May 28-29, 2024
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions. Open-market sales total $789.1K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Coleman MarkCIK 0001658379 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F3
Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $75.00 and $75.88.
Referenced by the price of 1 transaction in Table I.
- F4
Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $75.00 and $75.90.
Referenced by the price of 1 transaction in Table I.